IGM BIOSCIENCES, INC.
​Development of engineered IgM antibodies
- Active Clients
- 1
- TTM Spend
- $0
- Total Filings
- 14
- Active Since
- 2021
all-time
income + expenses, last 12mo
0 in the last 12 months
4 years with filings
Income & Lobbyist Activity Last 10 years, by quarter
Clients who have hired IGM BIOSCIENCES, INC. in the past (1) · ranked by reported income and expenses
| Client | Reported $ | Filings | Share |
|---|---|---|---|
| IGM BIOSCIENCES, INC. | $1.98M | 14 | 100.0% |
Issues lobbied 2024 Q1 – 2024 Q4, the firm's latest quarters on file
| Issue | Activities | Share |
|---|---|---|
MED
Medical/Disease Research/Clinical Labs
|
3 | 100.0% |
Government entities contacted 2024 Q1 – 2024 Q4, the firm's latest quarters on file
| Entity | Contacts | Share | Type |
|---|---|---|---|
| HOUSE OF REPRESENTATIVES | 3 | 50.0% | Congress |
| SENATE | 3 | 50.0% | Congress |
Revolving door lobbyists who have worked for the firm
0 of 1 lobbyist (0%) listed a prior covered government position on a lobbying filing.
Political contributions semiannual LD-203 reports by the firm and its lobbyists
No contribution reports on file for this firm.
Filings 14 total
| Posted | Period | Client | Type | Income | Expenses | Activities | Lobbyists |
|---|---|---|---|---|---|---|---|
| 2022-07-20 | 2022 Q2 | IGM BIOSCIENCES, INC. | 2nd Quarter - Report |
— | $130.0K | 1 | 1 |
| 2022-04-20 | 2022 Q1 | IGM BIOSCIENCES, INC. | 1st Quarter - Report |
— | $130.0K | 1 | 1 |
| 2022-01-20 | 2021 Q4 | IGM BIOSCIENCES, INC. | 4th Quarter - Report |
— | $140.0K | 1 | 1 |
| 2021-11-15 | 2021 Q4 | IGM BIOSCIENCES, INC. | Registration |
— | — | 1 | 1 |
Lobbyists who have worked for the firm (1)
- ANDREW WOMACK